FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2898813265> ?p ?o ?g. }

• W2898813265 endingPage "1872" @default.
• W2898813265 startingPage "1859" @default.
• W2898813265 abstract "Daratumumab, a human IgG monoclonal antibody targeting CD38, has demonstrated activity as monotherapy and in combination with standard-of-care regimens in multiple myeloma. Population pharmacokinetic analyses were conducted to determine the pharmacokinetics of intravenous daratumumab in combination therapy versus monotherapy, evaluate the effect of patient- and disease-related covariates on drug disposition, and examine the relationships between daratumumab exposure and efficacy/safety outcomes.Four clinical studies of daratumumab in combination with lenalidomide/dexamethasone (POLLUX and GEN503); bortezomib/dexamethasone (CASTOR); pomalidomide/dexamethasone, bortezomib/thalidomide/dexamethasone, and bortezomib/melphalan/prednisone (EQUULEUS) were included in the analysis. Using various dosing schedules, the majority of patients (684/694) received daratumumab at a dose of 16 mg/kg. In GEN503, daratumumab was administered at a dose of 2 mg/kg (n = 3), 4 mg/kg (n = 3), 8 mg/kg (n = 4), and 16 mg/kg (n = 34). A total of 650 patients in EQUULEUS (n = 128), POLLUX (n = 282), and CASTOR (n = 240) received daratumumab 16 mg/kg. The exposure-efficacy and exposure-safety relationships examined progression-free survival (PFS) and selected adverse events (infusion-related reactions; thrombocytopenia, anemia, neutropenia, lymphopenia, and infections), respectively.Pharmacokinetic profiles of daratumumab were similar between monotherapy and combination therapy. Covariate analysis identified no clinically important effects on daratumumab exposure, and no dose adjustments were recommended on the basis of these factors. Maximal clinical benefit on PFS was achieved for the majority of patients (approximately 75%) at the 16 mg/kg dose. No apparent relationship was observed between daratumumab exposure and selected adverse events.These data support the recommended 16 mg/kg dose of daratumumab and the respective dosing schedules in the POLLUX and CASTOR pivotal studies.Janssen Research & Development." @default.
• W2898813265 created "2018-11-09" @default.
• W2898813265 creator A5002972322 @default.
• W2898813265 creator A5004321069 @default.
• W2898813265 creator A5009395461 @default.
• W2898813265 creator A5012405296 @default.
• W2898813265 creator A5015598445 @default.
• W2898813265 creator A5016338515 @default.
• W2898813265 creator A5027778281 @default.
• W2898813265 creator A5035839686 @default.
• W2898813265 creator A5047122777 @default.
• W2898813265 creator A5054343933 @default.
• W2898813265 creator A5063858836 @default.
• W2898813265 creator A5067028141 @default.
• W2898813265 creator A5068837815 @default.
• W2898813265 creator A5078852881 @default.
• W2898813265 creator A5086077649 @default.
• W2898813265 creator A5087038322 @default.
• W2898813265 date "2018-10-29" @default.
• W2898813265 modified "2023-10-18" @default.
• W2898813265 title "Pharmacokinetics and Exposure–Response Analyses of Daratumumab in Combination Therapy Regimens for Patients with Multiple Myeloma" @default.
• W2898813265 cites W1585625390 @default.
• W2898813265 cites W1902692042 @default.
• W2898813265 cites W2021315742 @default.
• W2898813265 cites W2071843728 @default.
• W2898813265 cites W2140579395 @default.
• W2898813265 cites W2141502099 @default.
• W2898813265 cites W2167310857 @default.
• W2898813265 cites W2227353206 @default.
• W2898813265 cites W2229483068 @default.
• W2898813265 cites W2253038466 @default.
• W2898813265 cites W2400276917 @default.
• W2898813265 cites W2402003835 @default.
• W2898813265 cites W2443548094 @default.
• W2898813265 cites W2494994085 @default.
• W2898813265 cites W2510398184 @default.
• W2898813265 cites W2512106959 @default.
• W2898813265 cites W2528329272 @default.
• W2898813265 cites W2532646138 @default.
• W2898813265 cites W2551291014 @default.
• W2898813265 cites W2553693801 @default.
• W2898813265 cites W2557319359 @default.
• W2898813265 cites W2566631374 @default.
• W2898813265 cites W2584856244 @default.
• W2898813265 cites W2688500010 @default.
• W2898813265 cites W2756422634 @default.
• W2898813265 cites W2763640819 @default.
• W2898813265 cites W2772566228 @default.
• W2898813265 doi "https://doi.org/10.1007/s12325-018-0815-9" @default.
• W2898813265 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6223994" @default.
• W2898813265 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30374808" @default.
• W2898813265 hasPublicationYear "2018" @default.
• W2898813265 type Work @default.
• W2898813265 sameAs 2898813265 @default.
• W2898813265 citedByCount "21" @default.
• W2898813265 countsByYear W28988132652019 @default.
• W2898813265 countsByYear W28988132652020 @default.
• W2898813265 countsByYear W28988132652021 @default.
• W2898813265 countsByYear W28988132652022 @default.
• W2898813265 countsByYear W28988132652023 @default.
• W2898813265 crossrefType "journal-article" @default.
• W2898813265 hasAuthorship W2898813265A5002972322 @default.
• W2898813265 hasAuthorship W2898813265A5004321069 @default.
• W2898813265 hasAuthorship W2898813265A5009395461 @default.
• W2898813265 hasAuthorship W2898813265A5012405296 @default.
• W2898813265 hasAuthorship W2898813265A5015598445 @default.
• W2898813265 hasAuthorship W2898813265A5016338515 @default.
• W2898813265 hasAuthorship W2898813265A5027778281 @default.
• W2898813265 hasAuthorship W2898813265A5035839686 @default.
• W2898813265 hasAuthorship W2898813265A5047122777 @default.
• W2898813265 hasAuthorship W2898813265A5054343933 @default.
• W2898813265 hasAuthorship W2898813265A5063858836 @default.
• W2898813265 hasAuthorship W2898813265A5067028141 @default.
• W2898813265 hasAuthorship W2898813265A5068837815 @default.
• W2898813265 hasAuthorship W2898813265A5078852881 @default.
• W2898813265 hasAuthorship W2898813265A5086077649 @default.
• W2898813265 hasAuthorship W2898813265A5087038322 @default.
• W2898813265 hasBestOaLocation W28988132651 @default.
• W2898813265 hasConcept C112705442 @default.
• W2898813265 hasConcept C126322002 @default.
• W2898813265 hasConcept C143998085 @default.
• W2898813265 hasConcept C197934379 @default.
• W2898813265 hasConcept C2776063141 @default.
• W2898813265 hasConcept C2776364478 @default.
• W2898813265 hasConcept C2776999253 @default.
• W2898813265 hasConcept C2777063308 @default.
• W2898813265 hasConcept C2780401358 @default.
• W2898813265 hasConcept C2781119759 @default.
• W2898813265 hasConcept C2908647359 @default.
• W2898813265 hasConcept C29730261 @default.
• W2898813265 hasConcept C71924100 @default.
• W2898813265 hasConcept C98274493 @default.
• W2898813265 hasConcept C99454951 @default.
• W2898813265 hasConceptScore W2898813265C112705442 @default.
• W2898813265 hasConceptScore W2898813265C126322002 @default.
• W2898813265 hasConceptScore W2898813265C143998085 @default.
• W2898813265 hasConceptScore W2898813265C197934379 @default.
• W2898813265 hasConceptScore W2898813265C2776063141 @default.

• next